Table 5.
Mean risk scores and BP values (patients not at BP targets upon entry to study on visit 1)
| Outcome Measure | Visit | N | Control | SD | N | Intervention | SD |
|---|---|---|---|---|---|---|---|
| Adverse Behavior Risk | 1 | 24 | 20.8 | 19.5 | 26 | 23.3 | 19.8 |
| 2 | 23 | 15.4 | 13.0 | 23 | 16.1 | 12.0 | |
| 3 | 21 | 15.1 | 11.1 | 22 | 13.9 | 10.4 | |
| 4 | 21 | 18.5 | 15.1 | 22 | 11.7* | 8.2 | |
| SBP mm Hg | 1 | 24 | 139.9 | 10.7 | 26 | 146.2 | 9.8 |
| 2 | 23 | 133.7* | 15.8 | 25 | 139.0* | 16.4 | |
| 3 | 21 | 130.5 | 21.4 | 23 | 129.0* | 13.9 | |
| 4 | 21 | 133.8* | 13.3 | 22 | 130.6* | 11.5 | |
| DBP mm Hg | 1 | 24 | 77.5 | 8.3 | 26 | 81.1 | 11.6 |
| 2 | 23 | 73.6 | 7.0 | 25 | 79.5 | 13.1 | |
| 3 | 21 | 71.1* | 6.7 | 23 | 76.7 | 11.4 | |
| 4 | 21 | 75.2 | 8.8 | 22 | 74.8* | 9.2 |
*Post hoc paired t tests detected significant decrease (p < .05) compared to visit 1